Displaying items by tag: uab comprehensive cancer center
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care.
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
Tagged under
UAB is the first in the country to use novel HyperArc High-Definition Radiotherapy on brain cancer patients.
UAB Hospital has received a 2017 Women’s Choice Award for being one of America’s Best Breast Centers in the United States.
Tagged under
Several activities are planned in and around UAB for Breast Cancer Awareness Month.
Tagged under
Beating cancer means bridging gaps that put African Americans at greater risk of getting the disease and dying from it. Meet three trailblazing alumnae broadening the impact of lifesaving discoveries through research, education, and outreach, and hear their advice for budding scientists eager to follow in their footsteps.
Tagged under
These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.
Tagged under
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
UAB is the only institution in Alabama chosen to date to participate in the TAPUR Study to help further understand targeted therapies in patients with advanced cancers.
This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
Tagged under